Investor Relations

Corporate Overview

ENDRA is developing a next generation TAEUS® system to enable clinicians to quantify human tissue composition, function and temperature in ways previously possible only with biopsy and MRI – at a fraction of the cost, and at the point of care.

TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD) (formerly known as NAFLD-NASH), a chronic liver disease spectrum that affects over two billion people globally, and for which there are no practical diagnostic tools. The primary goal of TAEUS® is establishing key biomarkers for metabolic disease detection and management.

ENDRA is exploring several other clinical applications of TAEUS®, including monitoring of tissue temperature during energy-based surgical procedures.

Quick Links